COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL
Ezekowitz M, Parise H, Nagarakanti R, Noack H, Brueckmann M, Clemens A, Reilly P, Connolly S, Yusuf S, Wallentin L. COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL. Journal Of The American College Of Cardiology 2014, 63: a325. DOI: 10.1016/s0735-1097(14)60325-9.Peer-Reviewed Original Research